A Randomised Phase II Trial of Osimertinib with or without Stereotactic Radiosurgery for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases

Project: Research

Project Description

NMA HREC Reference Number: HREC/18/MH/53 (ERM Project ID 39668)
NMA SSA Reference Number: SSA/39668/MonH-2019-166033(v1)
Monash Health Ref: RES-19-0000-138X
Effective start/end date20/03/1919/03/24


  • clinical trial
  • treatment efficacy
  • lung cancer
  • phase 2 trial